|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 5/26 |
| (11) | Number of the document | 2871177 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14190028.2 |
| Date of filing the European patent application | 2008-09-11 | |
| (97) | Date of publication of the European application | 2015-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 960012 P | 2007-09-11 | US |
| (72) |
Ahn, Tai, US
Dalton, James, T., US
Dickason, Dave, US
Hong, David, US
Bird, Thomas, G., US
|
| (73) |
Oncternal Therapeutics, Inc.,
3525 Del Mar Heights Road Suite 821, San Diego, CA 92130-2122,
US
|
| (54) | Solid form of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide |
| Solid form of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide |